Shenzhen Chipscreen Biosciences Co RSI
Was ist das RSI von Shenzhen Chipscreen Biosciences Co?
RSI von Shenzhen Chipscreen Biosciences Co., Ltd. ist 37.12
Was ist die Definition von RSI?
Der relative Stärke-Index (RSI 14) ist ein Momentumindikator, der die Größe von Gewinnen und Verlusten über einen bestimmten Zeitraum vergleicht, um die Geschwindigkeit und die Änderung von Preisbewegungen eines Wertpapiers zu messen.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI von Unternehmen in Health Care Sektor auf SSE im Vergleich zu Shenzhen Chipscreen Biosciences Co
Was macht Shenzhen Chipscreen Biosciences Co?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Unternehmen mit rsi ähnlich Shenzhen Chipscreen Biosciences Co
- Biogen Inc Biogen Inc Ord Shs hat RSI von 37.10
- China Development hat RSI von 37.10
- Ninety One PLC hat RSI von 37.11
- Kohinoor Foods hat RSI von 37.11
- SuperCom Ltd hat RSI von 37.11
- Glatfelter hat RSI von 37.11
- Shenzhen Chipscreen Biosciences Co hat RSI von 37.12
- Carbios Sa Eo ,70 hat RSI von 37.13
- Prospector Metals Corp hat RSI von 37.13
- ChinaCache International hat RSI von 37.13
- Nutrien Ltd hat RSI von 37.13
- Menon Bearings hat RSI von 37.13
- Redington (India) hat RSI von 37.13